It is also not surprising for the module to include the well-established proto-oncogene MYC which has a wide spectrum of downstream effectors [49], [50], and the SLC family member SLC13A3, the expression of which found to be down-regulated in tumour cells over-expressing MYC family genes [51], [52]. This evidence concerns the gene SLC13A3 and neoplasm.